Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

J Cancer 2010; 1:1-5. doi:10.7150/jca.1.1 This volume Cite

Research Paper

Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study

Weifin Zeng1, Elisabeth J. Rushing2 ✉, Daniel P. Hartmann1, Norio Azumi1

1. Georgetown University Hospital, Washington, DC, USA
2. Department of Neuropathology and Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC, USA

✉ Corresponding author: Elisabeth J. Rushing, MD, Chair, Department of Neuropathology and Ophthalmic Pathology, Armed Forces Institute of Pathology, Washington, DC 20306-6000. Telephone: 202-782-3603; FAX: 202-782-4099; elisabeth.rushingcom

Citation:
Zeng W, Rushing EJ, Hartmann DP, Azumi N. Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study. J Cancer 2010; 1:1-5. doi:10.7150/jca.1.1. https://www.jcancer.org/v01p0001.htm
Other styles

File import instruction

Abstract

Background: The inhibitor of differentiation/DNA binding protein family (Id1-4) is involved in cell cycle control, tumorigenesis and angiogenesis through the negative regulation of helix-loop-helix transcription factors. Of these proteins, Id4 is known to play an important role in neural stem cell differentiation, and deregulation has been implicated in glial neoplasia. However, the expression and significance of Id4 in astrocytomas has not been fully addressed. Herein we report the differential expression of Id4 in astrocytomas of various grades using tissue microarrays (TMA) and immunohistochemistry (IHC).

Design: The GBM TMA was constructed from 53 archival cases at Georgetown University Hospital and a TMA with normal brain controls and grades II-III astrocytoma was obtained from Cybrdi (Rockville, MD). TMA sections were stained with Id4 antibody and the slides were scored according to the percentage of staining astrocytic nuclei (<9% -, 10-50% +, >51% ++). The Fisher Exact test was used to test for statistical significance.

Results: Nuclear staining for Id4 was seen in 73.58% GBMs, 25% grade III, and 12.5% grade II astrocytomas; staining was absent in normal brain tissue. There was a statistically significant difference between GBM and grades II, III astrocytoma (p <0.01). Significant Id4 expression was not detected in normal brain.

Conclusions: Our study confirms the frequent upregulation of Id4 expression in GBM, which lends support to its role in tumorigenesis, possibly in the transformation of low to high-grade astrocytoma (i.e. GBM). Further studies are warranted to determine the precise role of Id4 in glial neoplasia and its potential use in targeted therapy for GBM.

Keywords: glioblastoma, helix-loop-helix, Id4, immunohistochemistry, tissue microarray, transcription factor

Citation styles

APA
Zeng, W., Rushing, E.J., Hartmann, D.P., Azumi, N. (2010). Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study. Journal of Cancer, 1, 1-5. https://doi.org/10.7150/jca.1.1.

ACS
Zeng, W.; Rushing, E.J.; Hartmann, D.P.; Azumi, N. Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study. J. Cancer 2010, 1, 1-5. DOI: 10.7150/jca.1.1.

NLM
Zeng W, Rushing EJ, Hartmann DP, Azumi N. Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study. J Cancer 2010; 1:1-5. doi:10.7150/jca.1.1. https://www.jcancer.org/v01p0001.htm

CSE
Zeng W, Rushing EJ, Hartmann DP, Azumi N. 2010. Increased Inhibitor of Differentiation 4 (Id4) Expression in Glioblastoma: A Tissue Microarray Study. J Cancer. 1:1-5.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use